PhaseBio Pharmaceuticals, Inc. (PHAS)
Net Income Growth
124.95%
TTM · Period ending:
PHAS Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported124.95%period ending
Latest reported124.95%period ending
PHAS TTM Net Income YoY % (-81.14% → 124.95%)
Year-over-year change
High-resolution chart · PNG
PHAS net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| 124.9527% | |
| 114.3562% | |
| 99.867% | |
| -48.811% | |
| -69.6164% | |
| -136.9193% | |
| -151.1402% | |
| -142.5604% | |
| -124.5136% | |
| -75.2656% | |
| -64.5853% | |
| -52.3916% | |
| -81.1402% |